PFE (STOCKS)
Pfizer Inc.
$27.280000
+0.360000 (+1.34%)
Prev close: $26.920000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Albert Bourla
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $155,406.00M
- Employees
- 81,000
- P/E (TTM)
- 19.85
- P/B (TTM)
- 1.77
- Dividend Yield
- 638.93%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
9
Buy
17
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.66 | $0.58 | +0.0825 | +14.29% |
|
Sep 2025 (Q3)
|
$0.87 | $0.64 | +0.2303 | +36.00% |
|
Jun 2025 (Q2)
|
$0.78 | $0.59 | +0.1931 | +32.90% |
|
Mar 2025 (Q1)
|
$0.92 | $0.67 | +0.2507 | +37.46% |
Financial Statements
| Revenues | $62.58B |
| Benefits Costs and Expenses | $55.06B |
| Cost Of Revenue | $16.07B |
| Costs And Expenses | $55.06B |
| Gross Profit | $46.51B |
| Operating Expenses | $38.99B |
| Selling, General, and Administrative Expenses | $13.79B |
| Other Operating Expenses | $25.20B |
| Operating Income/Loss | $7.52B |
| Income/Loss From Continuing Operations After Tax | $7.79B |
| Income/Loss From Continuing Operations Before Tax | $7.52B |
| Income/Loss From Discontinued Operations Net Of Tax | $25.00M |
| Income Tax Expense/Benefit | -$266.00M |
| Income Tax Expense/Benefit, Current | $1.87B |
| Income Tax Expense/Benefit, Deferred | -$2.13B |
| Interest Expense, Operating | $2.67B |
| Net Income/Loss | $7.81B |
| Net Income/Loss Attributable To Noncontrolling Interest | $41.00M |
| Net Income/Loss Attributable To Parent | $7.77B |
| Net Income/Loss Available To Common Stockholders, Basic | $7.77B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.37 |
| Diluted Earnings Per Share | $1.36 |
| Basic Average Shares | 5,683,000,000 |
| Diluted Average Shares | 5,713,000,000 |
| Assets | $208.16B |
| Current Assets | $42.90B |
| Inventory | $10.65B |
| Other Current Assets | $32.24B |
| Noncurrent Assets | $165.26B |
| Fixed Assets | $19.32B |
| Intangible Assets | $53.73B |
| Other Non-current Assets | $92.21B |
| Liabilities | $121.39B |
| Current Liabilities | $36.98B |
| Accounts Payable | $5.24B |
| Wages | $3.61B |
| Other Current Liabilities | $28.13B |
| Noncurrent Liabilities | $84.40B |
| Equity | $86.78B |
| Equity Attributable To Noncontrolling Interest | $299.00M |
| Equity Attributable To Parent | $86.48B |
| Liabilities And Equity | $208.16B |
| Net Cash Flow From Operating Activities | $11.70B |
| Net Cash Flow From Operating Activities, Continuing | $11.70B |
| Net Cash Flow From Investing Activities | -$1.35B |
| Net Cash Flow From Investing Activities, Continuing | -$1.35B |
| Net Cash Flow From Financing Activities | -$10.30B |
| Net Cash Flow From Financing Activities, Continuing | -$10.30B |
| Exchange Gains/Losses | $41.00M |
| Net Cash Flow | $90.00M |
| Net Cash Flow, Continuing | $49.00M |
| Comprehensive Income/Loss | $7.57B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $29.00M |
| Comprehensive Income/Loss Attributable To Parent | $7.54B |
| Other Comprehensive Income/Loss | -$239.00M |